(ATHX:Consolidated Issue listed on NASDAQ Capital Market)
John Wagner M.D.
Scientific & Clinical Advisor, Athersys, Inc.
|Age||Total Calculated Compensation||This person is connected to 24 board members in 1 different organizations across 1 different industries.|
See Board Relationships
John Wagner, MD serves as Scientific and Clinical Advisor of BTHC VI, Inc. Dr. Wagner serves as Director of Hematology-Oncology & Transplantation Program. He is a leading experts in the field of bone marrow transplantation, studied from the University of Minnesota.
3201 Carnegie AvenuePhone: 216-431-9900
Cleveland, Ohio 44115
Board Members Memberships*There is no Board Members Memberships data available.
Education*There is no Education data available.
Other Affiliations*There is no Company Affiliations data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Michael D. West Ph.D.||Chief Executive Officer, President and Director|
|Marc H. Hedrick M.D.||Chief Executive Officer, President, Director and Member of Executive Committee|
Cytori Therapeutics, Inc.
|Martin M. McGlynn||Chief Executive Officer, Chief Executive Officer of Stemcells California Inc, President of Stemcells California Inc, Director and Member of Strategic Transactions Committee|
|Paul K. Wotton Ph.D.||Chief Executive Officer, President, Director and Member of Pricing Committee|
Ocata Therapeutics, Inc.
|Zami Aberman||Executive Chairman and Chief Executive Officer|
Pluristem Therapeutics, Inc.
|$503.7K||Compensation as of Fiscal Year 2013.|